Follow The Filings

GSK position history

The shares of GSK that Krensavage Asset Management LLC reported in each quarter’s 13F.

Equity, SPONSORED ADR

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q1: 272,000 shares, $11M, 5.8% of portfolio, New
  2. 2025 Q2: 271,729 shares, $10M, 5.5% of portfolio, Reduce −0.1%
  3. 2025 Q3: 271,729 shares, $12M, 5.0% of portfolio
  4. 2025 Q4: 96,729 shares, $4.7M, 1.7% of portfolio, Reduce −64.4%
  5. 2026 Q1: 96,729 shares, $5.3M, 2.1% of portfolio
  6. 2026 Q2: 96,729 shares, $5.1M, 1.9% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders